NRD
EOLS icon

Nebula Research & Development’s Evolus EOLS Stock Holding History

Nebula Research & Development’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,475
Closed -$95.7K – 710
2023
Q3 		$95.7K Buy
+10,475
New +$93.9K 0.05% 453

Other funds holding EOLS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Nebula Research & Development's EOLS Position: Q4 2023 in Review

Nebula Research & Development sold out of Evolus (EOLS) in Q4 2023, closing a stake of 10,475 shares — an estimated $95.7K sold.

Nebula Research & Development first reported a position in EOLS in Q3 2023 and held it in 1 quarter. The position peaked at $95.7K in Q3 2023. 151 funds tracked by Wall St. Rank hold EOLS as of Q4 2023.

  • Nebula Research & Development reported no remaining Evolus position as of Q4 2023 after selling out during the quarter.
  • Nebula Research & Development sold 10,475 Evolus shares in Q4 2023, an estimated $95.7K.
  • Nebula Research & Development first reported a position in Evolus in Q3 2023 and held it in 1 quarter.
  • Nebula Research & Development's Evolus position peaked at $95.7K in Q3 2023.
  • 151 funds tracked by Wall St. Rank held Evolus as of Q4 2023.

Based on Nebula Research & Development's 13F filing for Q4 2023, filed 14 Feb 2024.